USD
$0.00
(0.00%
)At Close (As of Sep 3, 2025)
$1.76B
Market Cap
52.18
P/E Ratio
0.11
EPS
$7.63
52 Week High
$3.38
52 Week Low
LIFE SCIENCES
Sector
Field | Value (USD) |
---|---|
Gross Profit | $209M |
Total Revenue | $286M |
Cost Of Revenue | $77M |
Costof Goods And Services Sold | $77M |
Operating Income | $73M |
Selling General And Administrative | $94M |
Research And Development | $46M |
Operating Expenses | $136M |
Investment Income Net | - |
Net Interest Income | -$25M |
Interest Income | $13M |
Interest Expense | $38M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $9M |
Income Before Tax | $31M |
Income Tax Expense | $2.9M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $28M |
Comprehensive Income Net Of Tax | - |
Ebit | $68M |
Ebitda | $77M |
Net Income | $28M |
Field | Value (USD) |
---|---|
Total Assets | $394M |
Total Current Assets | $268M |
Cash And Cash Equivalents At Carrying Value | $46M |
Cash And Short Term Investments | $46M |
Inventory | $28M |
Current Net Receivables | $12M |
Total Non Current Assets | $126M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $5.3M |
Intangible Assets Excluding Goodwill | $5.3M |
Goodwill | $1.9M |
Investments | - |
Long Term Investments | $5.5M |
Short Term Investments | $151M |
Other Current Assets | $31M |
Other Non Current Assets | - |
Total Liabilities | $473M |
Total Current Liabilities | $82M |
Current Accounts Payable | $6.8M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $13M |
Total Non Current Liabilities | $391M |
Capital Lease Obligations | $12M |
Long Term Debt | $36M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $48M |
Other Current Liabilities | $49M |
Other Non Current Liabilities | $292M |
Total Shareholder Equity | -$79M |
Treasury Stock | - |
Retained Earnings | -$3.2B |
Common Stock | $3M |
Common Stock Shares Outstanding | $284M |
Field | Value (USD) |
---|---|
Operating Cashflow | $43M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $9M |
Capital Expenditures | $9.7M |
Change In Receivables | - |
Change In Inventory | -$3.2M |
Profit Loss | - |
Cashflow From Investment | -$97M |
Cashflow From Financing | -$137M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $28M |
Field | Value (USD) |
---|---|
Gross Profit | $209M |
Total Revenue | $286M |
Cost Of Revenue | $77M |
Costof Goods And Services Sold | $77M |
Operating Income | $73M |
Selling General And Administrative | $94M |
Research And Development | $46M |
Operating Expenses | $136M |
Investment Income Net | - |
Net Interest Income | -$25M |
Interest Income | $13M |
Interest Expense | $38M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $9M |
Income Before Tax | $31M |
Income Tax Expense | $2.9M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $28M |
Comprehensive Income Net Of Tax | - |
Ebit | $68M |
Ebitda | $77M |
Net Income | $28M |
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California.